Communication Issues in Patient and Provider Discussions of Immunotherapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorEmory University
About this trial
This trials studies communication issues in patient and provider discussions about immunotherapy. The goal of this study is to describe where patients have heard about immunotherapy, what the participants understand about it, how physicians and other healthcare workers describe immunotherapy, and how educational videos may support patient knowledge about immunotherapy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
AIMS 1-3: All patients and providers who may have a discussion about immunotherapy at the Winship Cancer Institute
AIM 4: Any cancer patient
Disqualifiers
None
Trial design
Design model
Single group
Treatments tested in this trial
Educational video
Other interventionTesting an educational video
Interview
Other interventionParticipate in interview
Observation
Other interventionUndergo observation
Treatment groups
125 Participants
are divided into 2 treatment groupsGroup A: InterviewOther 2 interventions
Group B: Aim 4 tests an educational videoOther 1 intervention
Trial outcomes
Primary outcomes
1
Misestimations about the risks and benefits of immunotherapy resulting from media hype or other sources
Will use descriptive statistics to summarize the demographic characteristics and responses to the interviews. Will audio-record and transcribe the provider conversation for immunotherapy and the pre- and post-provider conversation interviews. The transcripts will be qualitatively coded using multi-level semantic analysis in MAXQDA. Pre-determined codes will include a list of potential benefits of immunotherapy, any patient estimation of the potential for benefit, any side effect and risk mentioned and any estimation of its frequency. Because there is no data on the frequency of misestimations due to media hype, no quantitative analysis is planned.
Time frame
Up to 4 years2
Qualitatively describe patient reported misunderstandings
During the observed conversation, the ethics team member will note any technical term or metaphor used. The patient will then be asked if each term and metaphor is understood. The open ended questions about misunderstanding, technical terms and metaphors used, and patients' understanding of each term will be qualitatively coded using multi-level semantic analysis in MAXQDA. Frequency of misunderstood terms and misunderstood metaphors will be calculated.
Time frame
Up to 4 years3
Provider and patient preferences for information to be communicated about immunotherapy
The frequencies of each item of information identified by providers and patients will be determined. A combined list of the most frequently mentioned items of information to be included and a discussion of immunotherapy will be compiled.
Time frame
Up to 4 years4
Correct definition rates (pre- versus post-video)
Before-video and after-video correct definition rates will be calculated, along with 95% exact binomial confidence intervals using the Clopper-Pearson method. Before and after paired rates will be compared using an exact McNemar's test. Subset analyses will be performed for gender, age group (=\< 55, \> 55), and education level (high school graduate or less, some college or more).
Time frame
Up to 4 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Emory University
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov